Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-11-12
pubmed:abstractText
The pharmacokinetics and dosage regimen of norfloxacin-glycine acetate (NFLXGA) was investigated in pigs after a single intravenous (i.v.) or oral (p.o.) administration at a dosage of 7.2 mg/kg body weight. After both i.v. and p.o. administration, plasma drug concentrations were best fitted to an open two-compartment model with a rapid distribution phase. After i.v. administration of NFLXGA, the distribution (t(1/2alpha)) and elimination half-life (t(1/2beta)) were 0.36 +/- 0.07 h and 7.42 +/- 3.55 h, respectively. The volume of distribution of NFLXGA at steady state (Vd(ss)) was 4.66 +/- 1.39 l/kg. After p.o. administration of NFLXGA, the maximal absorption concentration (C(max)) was 0.43 +/- 0.06 microg/ ml at 1.36 +/- 0.39 h (T(max)). The mean absorption (t(1/2ka)) and elimination half-life (t(1/2beta)) of NFLXGA were 0.78 +/- 0.27 h and 7.13 +/- 1.41 h, respectively. The mean systemic bioavailability (F) after p.o. administration was 31.10 +/- 15.16%. We suggest that the optimal dosage calculated from the pharmacokinetic parameters is 5.01 mg/kg per day i.v. or 16.12 mg/kg per day p.o.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-10447831, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-10678784, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-11020298, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-11180196, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-11555178, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-12204627, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-12379929, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-12507569, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-1466505, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-2306672, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-2389884, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-3282749, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-6237890, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-7629923, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-7674459, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-7839746, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-8735421, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-8863267, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-8916010, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-9597656, http://linkedlifedata.com/resource/pubmed/commentcorrection/17993748-9637308
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1229-845X
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
353-6
pubmed:dateRevised
2010-9-14
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Clinical pharmacokinetics of norfloxacin-glycine acetate after intravenous and oral administration in pigs.
pubmed:affiliation
College of Veterinary Medicine, Kyungpook National University, Daegu 702-701, Korea.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't